IMI International Medical Innovations

Predictive medicine company provides operational update

Published in Hospital Business Week, September 25th, 2005

Predictive medicine company IMI International Medical Innovations, Inc., (IMI; IME) announced financial results for the second quarter of fiscal 2005 ended June 30, 2005, and provided an update on operating activities.

"We have realized a number of important achievements in the first half of 2005 that will contribute significantly to the long-term value of the company," said Brent Norton, president and CEO. "We have started the 25,000-participant PREPARE (PREVU Predicts Atherosclerosis Risk and Events) clinical trial in the life insurance testing industry for PREVU LT (Lab Test) Skin Sterol Test, the lab-processed format of the technology - a study that includes LabOne...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hospital Business Week

Source: Hospital Business Week (2005-09-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry